KB
KALA BIO, Inc.
SEC filingPharmaceuticals · Arlington, MA
Amount raised$1.8Msold at filing
Total offering$1.8M
Investors in the raise1count reported to the SEC
FiledMar 17, 2026first sale Mar 3, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Yonatan ColmanDirector
Brendan PurdyDirector
Chaim BergerDirector
Avi MinkowitzExecutive Officer, Director
Hillel PosenDirector
Executive officers, directors and promoters as listed on the Form D.